# Konrad Rejdak, M.D. – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/konrad-rejdak-md/11a37c52-0af4-4ca9-ae20-1862fc12e96e
Source feed: FDA_Inspections

> FDA inspection 1206061 of Konrad Rejdak, M.D., May 19, 2023. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206061
- Company Name: Konrad Rejdak, M.D.
- Inspection Date: 2023-05-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Officers

- [Alanna L. Mussawwir Bias](https://www.keypedia.com/people/alanna-l-mussawwir-bias/514fda77-1849-4faf-af07-e62d7c6af58e)

Company: https://www.keypedia.com/companies/konrad-rejdak-md/bd5bc38b-1890-4cbb-9984-e9ba8d20a462

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d